Literature DB >> 25483649

Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.

Michael G Hanna1, Jason Howard, Jan Vermorken.   

Abstract

Entities:  

Keywords:  Bacillus Calmette Guerin (BCG); T-cell responses; active specific immunotherapy; colon tumor; delayed-typed hypersensitivity; human monoclonal antibodies; tumor heterogeneity; tumor immunity; tumor-associated antigens

Mesh：

Substances：

Year:  2014        PMID： 25483649      PMCID： PMC4514058          DOI： 10.4161/hv.28886

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  20 in total

Review 1.  PD-1 and its ligands in T-cell immunity.

Authors:  Mary E Keir; Loise M Francisco; Arlene H Sharpe
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

2.  Breakthrough of the year 2013. Cancer immunotherapy.

Authors:  Jennifer Couzin-Frankel
Journal:  Science       Date:  2013-12-20       Impact factor: 47.728

3.  Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

Authors:  J E Harris; L Ryan; H C Hoover; R K Stuart; M M Oken; A B Benson; E Mansour; D G Haller; J Manola; M G Hanna
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

4.  Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.

Authors:  Vincent A de Weger; Annelies W Turksma; Quirinus J M Voorham; Zelda Euler; Herman Bril; Alfons J van den Eertwegh; Elisabeth Bloemena; Herbert M Pinedo; Jan B Vermorken; Harm van Tinteren; Gerrit A Meijer; Erik Hooijberg
Journal:  Clin Cancer Res       Date:  2011-12-12       Impact factor: 12.531

5.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

6.  Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.

Authors:  M V Haspel; R P McCabe; N Pomato; N J Janesch; J V Knowlton; L C Peters; H C Hoover; M G Hanna
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

Review 7.  Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).

Authors:  Lothar H Finke; Kerry Wentworth; Brent Blumenstein; Natalie S Rudolph; Hyam Levitsky; Axel Hoos
Journal:  Vaccine       Date:  2007-09-27       Impact factor: 3.641

8.  The genomic landscapes of human breast and colorectal cancers.

Authors:  Laura D Wood; D Williams Parsons; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Steve Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James K V Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
Journal:  Science       Date:  2007-10-11       Impact factor: 47.728

Review 9.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

10.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962
View more
  2 in total

Review 1.  A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competition.

Authors:  M G Hanna; Jason D Howard
Journal:  Hum Vaccin Immunother       Date:  2017-03-24       Impact factor: 3.452

2.  Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy.

Authors:  Peter Rose; Natasja K van den Engel; Julia R Kovács; Rudolf A Hatz; Louis Boon; Hauke Winter
Journal:  Vaccines (Basel)       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.